Health Policy

Workshop on COVID-19 Public Policies at MIT

The Quest for Open Science: Truth of Covid19 Policy Response

Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials

June, 2022


Introduction: In 2020, prior to COVID-19 vaccine rollout, the Coalition for Epidemic Preparedness Innovations and Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We leveraged the Brighton Collaboration list to evaluate serious adverse events of special interest observed in phase III randomized trials of mRNA COVID-19 vaccines.

A Final Report Card on the States’ Response to COVID-19

April, 2022


Almost exactly two years ago COVID-19 spread to the United States. Following the federalism model, the 50 states and their governors and legislators made many of their own pandemic policy choices to mitigate the damage from the virus. States learned from one another over time about what policies worked most and least effectively in terms of containing the virus while minimizing the negative effects of lockdown strategies on businesses and children.

C19 Vax Strategy: Geert Vanden Bossche and Robert Malone, MD